Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage

被引:223
作者
Zhu, Y
Yang, GY
Ahlemeyer, B
Pang, L
Che, XM
Culmsee, C
Klumpp, S
Krieglstein, J
机构
[1] Univ Marburg, Inst Pharmakol & Toxikol, D-35032 Marburg, Germany
[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[3] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
关键词
TGF-beta; 1; neuroprotection; MAPK/Erk signaling; Bad phosphorylation; cerebral ischemia; rat hippocampal cells;
D O I
10.1523/JNEUROSCI.22-10-03898.2002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Despite the characterization of neuroprotection by transforming growth factor-beta1 (TGF-beta1), the signaling pathway mediating its protective effect is unclear. Bad is a proapoptotic member of the Bcl-2 family and is inactivated on phosphorylation via mitogen-activated protein kinase (MAPK). This study attempted to address whether MAPK signaling and Bad phosphorylation were influenced by TGF-beta1 and, furthermore, whether these two events were involved in the antiapoptotic effect of TGF-beta1. We found a gradual activation of extracellular signal-regulated kinase 1/2 (Erk1/2) and MAPK-activated protein kinase-1 (also called Rsk1) and a concomitant increase in Bad phosphorylation at Ser(112) in mouse brains after adenovirus-mediated TGF-beta1 transduction under nonischemic and ischemic conditions induced by transient middle cerebral artery occlusion. Consistent with these effects, the ischemia-induced increase in Bad protein level and caspase-3 activation were suppressed in TGF-beta1-transduced brain. Consequently, DNA fragmentation, ischemic lesions, and neurological deficiency were significantly reduced. In cultured rat hippocampal cells, TGF-beta1 inhibited the increase in Bad expression caused by staurosporine. TGF-beta1 concentration- and time-dependently activated Erk1/2 and Rsk1 accompanied by an increase in Bad phosphorylation. These effects were blocked by U0126, a mitogen-activated protein kinase/Erk kinase 1/2 inhibitor, suggesting an association between Bad phosphorylation and MAPK activation. Notably, U0126 and a Rsk1 inhibitor (Ro318220) abolished the neuroprotective activity of TGF-beta1 in staurosporine-induced apoptosis, indicating that activation of MAPK is necessary for the antiapoptotic effect of TGF-beta1 in cultured hippocampal cells. Together, we demonstrate that TGF-beta1 suppresses Bad expression under lesion conditions, increases Bad phosphorylation, and activates the MAPK/Erk pathway, which may contribute to its neuroprotective activity.
引用
收藏
页码:3898 / 3909
页数:12
相关论文
共 50 条
  • [21] Transforming growth factor-β in cancer and metastasis
    Jakowlew, Sonia B.
    CANCER AND METASTASIS REVIEWS, 2006, 25 (03) : 435 - 457
  • [22] Transforming growth factor-β messaging: #ContextMatters
    Guttmann-Gruber, C.
    Pinon Hofbauer, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (04) : 592 - 593
  • [23] Transforming growth factor-β in tumour development
    Trelford, Charles B.
    Dagnino, Lina
    Di Guglielmo, Gianni M.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [24] Transforming growth factor-β in myocardial disease
    Frangogiannis, Nikolaos G.
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (07) : 435 - 455
  • [25] The transforming growth factor-β superfamily of receptors
    de Caestecker, M
    CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (01) : 1 - 11
  • [26] Biology of Transforming Growth Factor-β Signaling
    Ikushima, Hiroaki
    Miyazono, Kohei
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2099 - 2107
  • [27] Transforming growth factor-β in cutaneous melanoma
    Javelaud, Delphine
    Alexaki, Vasileia-Ismini
    Mauviel, Alain
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 123 - 132
  • [28] Inhibition of human neutrophil degranulation by transforming growth factor-β1
    Shen, L.
    Smith, J. M.
    Shen, Z.
    Eriksson, M.
    Sentman, C.
    Wira, C. R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 149 (01) : 155 - 161
  • [29] Transforming growth factor-β1 expression in human acoustic neuroma
    Cardillo, MR
    Filipo, R
    Monini, S
    Aliotta, N
    Barbara, M
    AMERICAN JOURNAL OF OTOLOGY, 1999, 20 (01) : 65 - 68
  • [30] Heparin Inhibits Activation of Latent Transforming Growth Factor-β1
    Lee, Mee Jeong
    PHARMACOLOGY, 2013, 92 (5-6) : 238 - 244